Scotts Miracle-gro CO Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Mark D Kingdon, a Director of Scotts Miracle-Gro Co, sold 831 shares of common stock on August 10, 2026 for $61.65 per share.
NYSE
Hagedorn Partnership, L.P. reported changes in beneficial ownership of Scotts Miracle-Gro Co common stock on August 3, 2026.
NYSE
Mark J Scheiwer, EVP, CFO & CAO of Scotts Miracle-Gro Co, reported a transaction in 3 shares of common stock on July 31, 2026.
NYSE
Nathan Eric Baxter, President and CEO, a Director and 10% owner of Scotts Miracle-Gro Co, reported a transaction in 88 shares of common stock on July 31, 2026.
NYSE
Christopher Hagedorn, EVP & Chief Strategy Officer of Scotts Miracle-Gro Co, reported a transaction in 4 shares of common stock on July 31, 2026.
NYSE
Stephen L Johnson, a Director of Scotts Miracle-Gro Co, sold 1,171 shares of common stock on July 30, 2026 for $68.32 per share.
NYSE
Mark J Scheiwer, EVP, CFO & CAO of Scotts Miracle-Gro Co, received 4 shares of common stock on July 27, 2026.
NYSE
Director Stephen L. Johnson of The Scotts Miracle-Gro Company acquired 105 common shares through a deferred stock unit conversion.
NYSE
Mark J. Scheiwer, EVP, CFO & CAO of Scotts Miracle-Gro Co, acquired company shares through a 10b5-1 plan.
NYSE
Christopher Hagedorn, EVP & Chief of Staff at Scotts Miracle-Gro, reported a transaction involving the sale of common shares.
NYSE
Nick Miaritis, EVP & Chief Brand Officer at Scotts Miracle-Gro, reported a transaction involving common shares.
NYSE
Nathan Eric Baxter, President and CEO of The Scotts Miracle-Gro Company, has acquired a significant number of common shares.
NYSE
Brian E. Sandoval, a Director at The Scotts Miracle-Gro Company, acquired 420 common shares through a transaction valued at $68.57 per share.
NYSE
Mark J. Scheiwer, EVP, CFO & CAO of The Scotts Miracle-Gro Company, reported a transaction involving phantom stock.
NYSE
James Hagedorn, CEO and Director of Scotts Miracle-Gro, acquired 1,272.152 phantom shares on June 26, 2026, valued at $71.01 each.
NYSE
Stephen L. Johnson, a Director at The Scotts Miracle-Gro Company, reported a transaction involving dividend equivalent rights.
NYSE
Mark J. Scheiwer, EVP, CFO & CAO of The Scotts Miracle-Gro Company, reported transactions involving common shares and phantom stock.
NYSE
Form 4: Baxter Acquires SMG Shares
Nathan Eric Baxter, a director and 10% owner of The Scotts Miracle-Gro Company, acquired 98.951 shares of common stock on May 29, 2026.
NYSE
Peter E. Shumlin, a Director at The Scotts Miracle-Gro Company, has acquired 173 dividend equivalent rights, representing common shares.
NYSE
David C. Evans, a Director at The Scotts Miracle-Gro Company, reported a transaction involving dividend equivalent rights.
NYSE
Edith Aviles, a Director at The Scotts Miracle-Gro Company, reported a transaction involving dividend equivalent rights.
NYSE
Adam Hanft, a Director at The Scotts Miracle-Gro Company, reported a transaction involving dividend equivalent rights.
NYSE
Roberto Candelino, a Director at The Scotts Miracle-Gro Company, acquired dividend equivalent rights related to his equity grants.
NYSE
Christopher Hagedorn, EVP & Chief of Staff at The Scotts Miracle-Gro Company, acquired 4,294 common shares.
NYSE
Mark D. Kingdon, a Director at The Scotts Miracle-Gro Company, reported a transaction involving dividend equivalent rights.
NYSE
Scotts Miracle-Gro Director Nick Miaritis acquired 74 dividend equivalent rights on June 5, 2026, related to his holdings.
NYSE
Katherine Hagedorn Littlefield, a Director at The Scotts Miracle-Gro Company, acquired dividend equivalent rights related to her holdings.
NYSE
Austin Scott Miller, a Director at Scotts Miracle-Gro Co., acquired 55 dividend equivalent rights on June 5, 2026, as detailed in a Form 4 filing.
NYSE
James Hagedorn, Chairman & CEO of Scotts Miracle-Gro Co., reported transactions involving common shares and phantom stock, acquiring shares and exercising phantom stock rights.
NYSE
Brian E. Sandoval, a Director at The Scotts Miracle-Gro Company, reported a transaction involving dividend equivalent rights.